| Product Code: ETC6735465 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China AI In Oncology Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China AI In Oncology Market Revenues & Volume, 2021 & 2031F |
3.3 China AI In Oncology Market - Industry Life Cycle |
3.4 China AI In Oncology Market - Porter's Five Forces |
3.5 China AI In Oncology Market Revenues & Volume Share, By Component Type, 2021 & 2031F |
3.6 China AI In Oncology Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.7 China AI In Oncology Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 China AI In Oncology Market Revenues & Volume Share, By End-use Type, 2021 & 2031F |
4 China AI In Oncology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer cases in China |
4.2.2 Growing adoption of AI technology in healthcare sector |
4.2.3 Government initiatives and investments in AI research and development for oncology |
4.3 Market Restraints |
4.3.1 Data privacy and security concerns |
4.3.2 High initial implementation costs of AI technology in oncology |
4.3.3 Limited availability of skilled professionals in AI and oncology field |
5 China AI In Oncology Market Trends |
6 China AI In Oncology Market, By Types |
6.1 China AI In Oncology Market, By Component Type |
6.1.1 Overview and Analysis |
6.1.2 China AI In Oncology Market Revenues & Volume, By Component Type, 2021- 2031F |
6.1.3 China AI In Oncology Market Revenues & Volume, By Software Solutions, 2021- 2031F |
6.1.4 China AI In Oncology Market Revenues & Volume, By Hardware, 2021- 2031F |
6.1.5 China AI In Oncology Market Revenues & Volume, By Services, 2021- 2031F |
6.2 China AI In Oncology Market, By Cancer Type |
6.2.1 Overview and Analysis |
6.2.2 China AI In Oncology Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.2.3 China AI In Oncology Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.2.4 China AI In Oncology Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.2.5 China AI In Oncology Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.2.6 China AI In Oncology Market Revenues & Volume, By Brain TumorOthers, 2021- 2031F |
6.3 China AI In Oncology Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 China AI In Oncology Market Revenues & Volume, By Diagnostics (Pathology, Cancer Radiology), 2021- 2031F |
6.3.3 China AI In Oncology Market Revenues & Volume, By Radiation Therapy (Radiotherapy), 2021- 2031F |
6.3.4 China AI In Oncology Market Revenues & Volume, By Research & Development (Drug design, development process, etc.), 2021- 2031F |
6.3.5 China AI In Oncology Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.3.6 China AI In Oncology Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
6.4 China AI In Oncology Market, By End-use Type |
6.4.1 Overview and Analysis |
6.4.2 China AI In Oncology Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 China AI In Oncology Market Revenues & Volume, By Surgical Centers & Medical Institutes, 2021- 2031F |
6.4.4 China AI In Oncology Market Revenues & Volume, By Others, 2021- 2031F |
7 China AI In Oncology Market Import-Export Trade Statistics |
7.1 China AI In Oncology Market Export to Major Countries |
7.2 China AI In Oncology Market Imports from Major Countries |
8 China AI In Oncology Market Key Performance Indicators |
8.1 Average time saved in diagnosing cancer through AI algorithms |
8.2 Accuracy rate of AI systems in detecting and predicting cancer progression |
8.3 Number of research collaborations between AI companies and oncology institutions |
9 China AI In Oncology Market - Opportunity Assessment |
9.1 China AI In Oncology Market Opportunity Assessment, By Component Type, 2021 & 2031F |
9.2 China AI In Oncology Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.3 China AI In Oncology Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 China AI In Oncology Market Opportunity Assessment, By End-use Type, 2021 & 2031F |
10 China AI In Oncology Market - Competitive Landscape |
10.1 China AI In Oncology Market Revenue Share, By Companies, 2024 |
10.2 China AI In Oncology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here